-David Siegel Researcher Activity Profile

Research Author Detailed Information 

David Siegel Publication Rate By Year

David Siegel has published 12 paper(s) in 2007, 3 paper(s) in 2008, for a total of 15 research publications in total.

David D Siegel Author Information

LAST NAME: siegel

FIRST NAME: david

INITIALS: D

AFFILIATION:

Papers

David Siegel's Publication Record

1. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis Medical Center, Davis, CA, USA.
2. Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity. Year Published: 2007
School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom.
3. A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings. Year Published: 2007
Hematology/Oncology Division, University of Pennsylvania Health System, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA, edward.stadtmauer@uphs.upenn.edu.
4. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. Year Published: 2007
Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX 77030, USA. dmweber@mdanderson.org
5. A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings. Year Published: 2007
Hematology/Oncology Division, University of Pennsylvania Health System, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA, edward.stadtmauer@uphs.upenn.edu.
6. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis Medical Center, Davis, CA, USA.
7. Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men. Year Published: 2007
Western Human Nutrition Research Center, Agricultural Research Service, USDA and Department of Nutrition, University of California, Davis, CA 95616, USA. darshan.kelley@ars.usda.gov
8. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Year Published: 2007
Laboratory for Atherosclerosis and Metabolic Research, University of California, Davis Medical Center, Davis, CA, USA.
9. Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity. Year Published: 2007
School of Chemistry, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom.
10. Docosahexaenoic acid supplementation decreases remnant-like particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men. Year Published: 2007
Western Human Nutrition Research Center, Agricultural Research Service, USDA and Department of Nutrition, University of California, Davis, CA 95616, USA. darshan.kelley@ars.usda.gov
11. Coumarin-based inhibitors of human NAD(P)H: quinone oxidoreductase-1. identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity. Year Published: 2007
School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
12. Spontaneous isolated dissection of the celiac artery: CT findings in adults. Year Published: 2007
Department of Radiology, Long Island Jewish Medical Center, 270-05 76th Ave., New Hyde Park, NY 11040, USA. dambrosn@hotmail.com
13. The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients. Year Published: 2008
Medical Service, Department of Veterans Affairs, Northern California Health Care System, Mather, California, USA. david.siegel@va.gov
14. The effect of body mass index on fasting blood glucose after initiation of thiazide therapy in hypertensive patients. Year Published: 2008
[1] 1Medical Service, Department of Veterans Affairs, Northern California Health Care System, Mather, California, USA [2] 2Department of Medicine, School of Medicine, University of California, Davis, California, USA.
15. Effects of antihypertensives on glucose metabolism. Year Published: 2008
Medical Service, Department of Veterans Affairs, Northern California Health Care System, Mather, CA, Department of Medicine, School of Medicine, University of California, Davis.